PMC-201 (PharmAbcine)

N/A

Report date: 2025/03/20 14:43:20

Base Information

Drug NamePMC-201 (PharmAbcine)

Drug Alias NamePMC-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsDelta-like protein 4 inhibitors

TargetsVascular endothelial growth factor receptor 2Delta-like protein 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPharmAbcine Inc

China Registration ClassN/A

Develop Information

Active CompaniesPharmAbcine Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A